123 related articles for article (PubMed ID: 1187699)
1. Effect of phenformin on the response of plasma intestinal glucagon-like immunoreactivity (GLI) to oral glucose in gastrectomized subjects.
Shima K; Sawazaki N; Morishita S; Tarui S; Nishikawa M
Proc Soc Exp Biol Med; 1975 Oct; 150(1):232-6. PubMed ID: 1187699
[TBL] [Abstract][Full Text] [Related]
2. The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.
Czyzyk A; Heding LG; Malczewski B; Miedzinska E
Diabetologia; 1975 Apr; 11(2):129-33. PubMed ID: 168107
[TBL] [Abstract][Full Text] [Related]
3. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
Yasui K
Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
[TBL] [Abstract][Full Text] [Related]
4. Production of antisera to des Asn28 Thr29 Homoser27-glucagon; the development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma.
Nishino T; Kodaira T; Shin S; Imagawa K; Yanaihara N; Shima K; Kumahara Y
Endocrinol Jpn; 1981 Aug; 28(4):419-27. PubMed ID: 6897834
[TBL] [Abstract][Full Text] [Related]
5. Plasma glucagon-like immunoreactivity (GLI) in dogs.
Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
Marco J; Hedo JA; Villaneuva ML
J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
[TBL] [Abstract][Full Text] [Related]
7. Effect of food ingestion on intestinal glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects.
Marco J; Hedo JA; Villanueva ML; Calle C; Corujedo A; Segovia JM
Diabetologia; 1977 Apr; 13(2):131-5. PubMed ID: 856651
[TBL] [Abstract][Full Text] [Related]
8. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
[TBL] [Abstract][Full Text] [Related]
9. Gastric operations and glucose homeostasis. II. glucagon and secretin.
Breuer RI; Zuckerman L; Hauch TW; Green W; O'Gara P; Lawrence AM; Foà PP; Matsuyama T
Gastroenterology; 1975 Sep; 69(3):598-606. PubMed ID: 1158076
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of glucagon-like polypeptides in gastrectomized patients transformed from Billroth II into Billroth I.
Tamburrano G; Mauceri M; Lala A; Tonelli F; Leonetti F; Andreani D
Horm Metab Res; 1982 Dec; 14(12):642-5. PubMed ID: 7152478
[TBL] [Abstract][Full Text] [Related]
11. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
Saudek CD; Finkowski M; Knopp RH
J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
[TBL] [Abstract][Full Text] [Related]
12. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of glucagon-like polypeptides in patients with esophagoplasty.
Tamburrano G; Lala A; Mauceri M; Tonelli F; Leonetti F; Andreani D
J Endocrinol Invest; 1982; 5(2):107-9. PubMed ID: 6896521
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
16. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
[TBL] [Abstract][Full Text] [Related]
17. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
Karmann H; Mialhe P
Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
[TBL] [Abstract][Full Text] [Related]
18. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
[TBL] [Abstract][Full Text] [Related]
20. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
Bajorunas DR; Fortner JG; Jaspan JB
Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
